Home Drug Codes C Codes C9302 · ZIIHERA
Updated July 1st, 2026

ZIIHERA C Code: C9302

Injection, zanidatamab-hrii, 2 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, zanidatamab-hrii, 2 mg
HCPCS Added Date April 1, 2025
Manufacturer Jazz Pharmaceuticals
Route of Administration Intravenous
Generic Status HCPCS Discontinued
Dosage Type Single-Dose
Dosage Form Injection, Powder, Lyophilized, For Solution

About ZIIHERA

Ziihera is a medication aligned to the HCPCS C Code: C9302 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Jazz Pharmaceuticals.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to C9302. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

ZIIHERA CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

ZIIHERA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Biliary Tract Cancer Gastric, gastroesophageal junction, or esophageal adenocarcinoma
Drug Class
Bispecific HER2-directed Antibody [EPC]HER2-directed Antibody Interactions [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there a manufacturer-published ZIIHERA billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for ZIIHERA.
What are the available ZIIHERA patient assistance programs?
Our team has not identified a manufacturer-published source of patient assistance information for ZIIHERA.
Where can I find ZIIHERA prescribing information?
ZIIHERA prescribing information can be found at the link below. Visit Here →
Where can I find ZIIHERA side effect information?
Our team has not identified a source of side effect information for ZIIHERA.
Does billing ZIIHERA require JZ/JW wastage modifiers?
CMS does not include ZIIHERA (C9302) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing C9302. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.